Aquilon Pharmaceuticals
PRIVATE
STATUS
Series A
LATEST DEAL TYPE
$387K
LATEST DEAL AMOUNT
2
INVESTORS
Description
Operator of a pharmaceutical company developing drugs for the treatment of pulmonary diseases. The company focuses on the development of drugs for the treatment of respiratory disorders.
Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
- 76 Rue Porte de Lorette
- 4600 Vise
- Belgium
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Aquilon Pharmaceuticals’s full profile, request a free trial.
Aquilon Pharmaceuticals Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Angel (individual) | 26-Oct-2015 | $387K | 00000 | 00000 | Completed | Startup |
| 1. Accelerator/Incubator | 14-Nov-2011 | Completed | Startup |
Aquilon Pharmaceuticals Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Be Angels | Angel Group | Minority | 000 0000 | 000000 0 | ||
| WBC | Accelerator/Incubator | 000 0000 | 000000 0 |
Aquilon Pharmaceuticals Executive Team (4)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Paul Maes | Chief Executive Officer & Chairman | ||
| Didier Cataldo | Co-Founder & Administrator | ||
| Brigitte Evrard | Co-Founder |
1 Former Executive
You’re viewing 3 of 4 executives. Get the full list »Aquilon Pharmaceuticals Board Members (1)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Paul Maes | Aquilon Pharmaceuticals | Chief Executive Officer & Chairman | 000 0000 |